粘膜皮肤淋巴结综合征

粘膜皮肤淋巴结综合征的相关文献在1998年到2021年内共计104篇,主要集中在儿科学、内科学、临床医学 等领域,其中期刊论文104篇、专利文献134621篇;相关期刊38种,包括医学临床研究、中国临床医学影像杂志、中华超声影像学杂志等; 粘膜皮肤淋巴结综合征的相关文献由295位作者贡献,包括李成荣、李卓颖、杜忠东等。

粘膜皮肤淋巴结综合征—发文量

期刊论文>

论文:104 占比:0.08%

专利文献>

论文:134621 占比:99.92%

总计:134725篇

粘膜皮肤淋巴结综合征—发文趋势图

粘膜皮肤淋巴结综合征

-研究学者

  • 李成荣
  • 李卓颖
  • 杜忠东
  • 杨作成
  • 向慧娟
  • 常青
  • 李永柏
  • 杨军
  • 杨锡强
  • 王国兵
  • 期刊论文
  • 专利文献

搜索

排序:

年份

    • 何学华; 朱潜力; 袁勇华; 龙湘党; 夏晓辉; 王胜; 胡灿
    • 摘要: 目的 探讨川崎病合并冠状动脉瘤患儿应用华法林治疗的安全性和转归.方法 选择2011至2020年湖南省人民医院收治的川崎病合并巨大冠状动脉瘤、1支冠状动脉血管内发生多个冠状动脉瘤或冠状动脉内发生血栓的患儿共21例进行前瞻性研究,应用华法林治疗,将国际标准化比值(INR)目标范围控制在2.0~3.0.在治疗开始时,治疗后1、2、3、4周及2、3、6、12个月,观察治疗前后冠状动脉瘤直径、数量、部位和冠状动脉内血栓的变化,并监测INR、心电图、肌酸激酶同工酶(CK-MB)、肌钙蛋白I.实施规范的华法林出血风险培训与管理,并根据家长实际落实情况,分为落实组和未落实组,比较2组患儿出血的发生情况.组间比较采用秩和检验或Fisher确切概率法.结果 21例患儿男15例、女6例,发病年龄为2月龄至6岁.入组时评估冠状动脉病变为II级有4例、I级有7例、IV级有7例、V级有3例.10例发生血栓的患儿临床发现血栓的时间为病程第4天至4个月.应用华法林治疗后,其剂量分布在0.06~0.10mg/(kg·d),INR为1.80~2.59,10例有血栓的患儿有8例消失,2例未消失的V级患儿的血栓有不同程度机化.治疗后,4例Ⅱ级病变患儿的冠状动脉均恢复正常;7例1级病变患儿中有3例冠状动脉瘤消失,4例无改变;7例I级病变患儿中5例冠状动脉瘤缩小为ⅢI级,2例无改变;3例V级病变患儿瘤体无改变.治疗后均没有新发血栓及新冠状动脉瘤出现.21例患儿治疗前后心电图无特殊改变,治疗前后肌钙蛋白I和CK-MB差异均无统计学意义[0.07(0?3.01)比0.04(0~0.29)μ,g/L,20.6(11.2~58.2)比29.0(16.7~47.0)U/L,Z=0.932、1.906,均 P>0.05].华法林出血风险管理落实组患儿出血发生率明显低于未落实组,差异有统计学意义(2/15比4/6,Fisher值=5.689,P=0.031).结论 应用INR2.0~3.0为目标范围,结合川崎病并冠状动脉瘤的严重程度来调整华法林剂量,并予以规范而严格的管理与培训,可增加川崎病患儿华法林治疗的安全性,改善患儿的冠状动脉病变,治疗血栓及预防新血栓,降低出血风险.
    • 熊祎; 张永兰; 杜忠东
    • 摘要: 目的 总结分析川崎病合并巨大冠状动脉瘤(GCAA)患儿的临床特点及中长期预后.方法 回顾性队列研究.自首都医科大学附属北京儿童医院2004年建立的川崎病冠状动脉瘤随诊患儿队列中选择符合标准的101例GCAA患儿进行总结.GCAA诊断标准为冠状动脉瘤内径≥8.0 mm,患儿均完成定期随诊.随访终点为患儿最后一次随诊或死亡时间.组间比较采用t检验或x2检验.结果 101例符合纳入标准GCAA患儿入选研究对象,其中男82例(81.2%)、女19例(18.8%);发病年龄2.5(1.0,4.5)岁,随访时间4.5(2.7,7.5)年,最长19年.患儿常规接受阿司匹林、华法林治疗,严重者另加氯吡格雷.截至随访终点,13例(12.9%)患儿出现心脏增大,11例(10.9%)合并心功能不全,13例(12.9%)发生心肌梗死,2例(2.0%)接受冠状动脉搭桥术,6例(5.9%)死亡.受累冠状动脉共170支,位于左侧主干24支(14.1%),左回旋支10支(5.9%),左前降支57支(33.5%),右侧冠状动脉中段78支(45.9%),右侧冠状动脉远段1支(0.6%).11例(10.9%)患儿GCAA内径回缩至4.0 mm及以下;受累的170支冠状动脉中,28支(16.5%)冠状动脉内径回缩到4.0 mm及以下.左侧、右侧GCAA回缩情况差异无统计学意义[18.7%(17/91)比13.9%(11/79),x2=2.473,P=0.116].单侧GCAA与双侧GCAA患儿回缩情况差异无统计学意义[16.1%(9/56)比4.4%(2/45),x2=2.381,P=0.123].结论 川崎病GCAA以右冠状动脉中段、左冠状动脉前降支最常见,患儿心血管事件发生率及病死率较高,预后欠佳.
    • 谭傲雪; 唐雪梅
    • 摘要: 目的 总结川崎病再发的临床特征并探讨其危险因素.方法 回顾性分析2013年1月至2021年1月于重庆医科大学附属儿童医院风湿免疫科收治的因川崎病2次及以上入院的41例患儿(再发组)临床资料.并用简单随机数字法选取于本院随访至少6年无再发的123例川崎病患儿作为对照组.再发组根据发作的时间分为初发时和再发时.总结川崎病再发的临床特征,采用x2检验和Mann-Whitney U检验比较初发时和对照组危险因素的差异,并进行二元Logistic回归分析,并对相关因素进行受试者工作特征曲线分析.结果 再发组41例患儿中男29例、女12例,其中33例(80%)于初发后2年内再发,8例(20%)于2年后再发.再发时外周血白细胞计数、静脉丙种球蛋白冲击前发热时间、指趾端硬肿均低于初发时[15.2 (12.8~18.8) ×109比18.0 (14.9~23.4)×109/L、5.0(5.0~6.0)比6.0(5.0~7.5)d、54%(22/41)比76%(31/41),Z=-2.462、-3.329,x2=4.321,均P<0.05],再发时血红蛋白、血清白蛋白水平均高于初发时[(116±8)比(107±12)g/L、(39±5)比(36±6)g/L,t=-4.124、-3.009,均P<0.05].多因素Logistic回归分析显示,C反应蛋白>97.5 mg/L(OR=3.014,95%CI 1.350~6.730,P=0.007)、血小板>276× 109/L(OR=4.099,95%CI1.309~12.838,P=0.015)、丙种球蛋白耐药(OR=9.239,95%CI 1.178~72.477,P=0.034)、肺炎支原体感染(OR=2.585,95%CI 1.129~5.922,P=0.025)均为川崎病再发的独立危险因素.经受试者工作特征曲线分析得出模型预测川崎病再发的曲线下面积为0.732(95%CI0.647~0.817),截断值为0.241时,灵敏度为63.4%,特异度为70.7%.结论 川崎病初次发作后应该至少密切随访2年,同时密切关注C反应蛋白值;初发时有肺炎支原体感染、丙种球蛋白耐药、C反应蛋白及血小板值升高的患儿发生川崎病再发风险更高.
    • 李朋烛; 詹霞; 谢圭; 刘欣; 钱玉洁; 李卓颖; 黄利华; 杨作成
    • 摘要: 目的 探讨川崎病(KD)患儿骨桥蛋白(OPN)基因708C/T位点多态性的特点,以及与冠状动脉损伤(CAL)的关联性.方法 选择2006年10月至2015年3月,在中南大学湘雅三医院儿科住院治疗的103例KD患儿(KD组),及同期在医院进行体检的100例健康儿童(对照组)为研究对象.采取病例对照研究方法,应用聚合酶链反应-限制性内切酶片断长度多态性分析(PCR-RFLP)技术,对203例受试者的OPN基因708C/T位点多态性进行分析.KD组根据有无CAL分为KD合并CAL组(n=43)和KD无CAL组(n=60).结果 KD组OPN基因708C/T位点3种基因型分布频率分别为CC(9,8.74%)、CT(30,29.13%)和TT(64,62.14%),等位基因频率为C(48,23.30%)和T(158,76.70%);正常对照组OPN基因708C/T位点3种基因型分布频率分别为CC(8,8.00%)、CT(35,35.00%)和TT(57,57.00%),等位基因频率C(51,25.50%)、T(149,74.50%);两组比较,均差异无统计学意义(χ2=0.79,0.28;均P>0.05);KD合并CAL组中OPN基因708C/T位点基因型[CC(3,6.98%)、CT(15,34.88%)、TT(25,58.14%)]及等位基因频率[C(21,24.42%)、T(65,75.58%)]与KD未合并CAL组[CC(6,10.00%)、CT(14,23.33%)、TT(40,66.67%),C(26,21.67%)、T(94,78.33%)]比较,均差异无统计学意义(χ2=1.73,0.22;均P>0.05).结论 未发现OPN基因708C/T位点多态性与KD的发生及其并发CAL存在关联性.
    • He Lan; Liu Fang; Huang Guoying; Wu Lin; Chu Chen; Lu Ying
    • 摘要: 目的 分析冠状动脉造影(CAG)在儿童川崎病合并冠状动脉病变(CAL)中的应用.方法 回顾性分析2006年6月至2018年6月在复旦大学附属儿科医院住院的139例川崎病合并CAL患儿的临床资料,男115例,女24例,年龄(48±42)月龄,经超声心动图检查评估为CAL临床严重程度分级Ⅲ级及以上,经家长签署同意书后在全身麻醉下进行CAG检查,分析CAG的安全性、图像获取的满意度及并发症、CAL的分布情况,根据CAG检查结果给予不同治疗及随访方案.结果 共139例川崎病患儿行CAG,其中17例患儿行重复造影.共有309支冠状动脉发生病变,平均每例患儿有2.22支冠状动脉发生病变.CAG后139例患儿的临床严重程度分级分别为:Ⅲ级33例,Ⅳ级56例,Ⅴa级33例,Ⅴb级17例.其中10例(7.2%)患儿仅做主动脉根部造影,其余129例(92.8%)患儿行选择性左右CAG.27例(19.4%)患儿冠状动脉瘤内有血栓形成;23例(16.5%)患儿有冠状动脉狭窄;4例(2.9%)患儿右冠状动脉阻塞后再通.所有患儿均获得满意图像,无并发症发生.Ⅴb级患儿中8例行冠状动脉搭桥手术,1例患儿由于严重心力衰竭手术中死亡,其余7例手术顺利,术后随访18~108个月恢复良好.结论 在川崎病CAL患儿中进行CAG安全,可获取满意图像;根据CAG进行CAL临床严重程度分级并给予相应手术治疗方案,中长期随访可获得满意效果.%Objective To investigate the application of coronary angiography (CAG) in children with Kawasaki disease complicated with coronary artery lesion (CAL).Methods A total of 139 patients (115 boys and 24 girls,age (48±42) months) with Kawasaki disease complicated with CAL underwent CAG between June 2006 and June 2018 in Children's Hospital of Fudan University.CAL in all children were at grade Ⅲ and above assessed by echocardiography and underwent CAG under general anesthesia with parental consent.A retrospective analysis was performed to identify the safety and complication of CAG,degree of satisfaction of image,distribution of CAL,and the treatment and follow-up management according to the result of CAG.Results All the 139 patients underwent CAG,and 17 patients received CAG twice.In these cases,there was a total of 309 CAL with an average of 2.22 CAL per patient.After CAG,children were re-graded as grade Ⅲ in 33 cases,grade Ⅳ in 56 cases,grade Ⅴ a in 33 cases and grade Ⅴ b in 17 cases according to the clinical severity.Ten patients (7.2%) had only aortic root angiography and 129 (92.8%) patients had selective left or right CAG.Among these,27 cases (19.4%) showed thrombosis in coronary aneurysm,23 cases (16.5%) showed coronary artery stenosis,4 cases (2.9%) showed recanalization after occlusion in right coronary artery.All the patients obtained satisfied images,and no complication was found.Eight of the grade Ⅴ b patients underwent coronary artery bypass grafting (CABG).One patient died during the surgery due to severe heart failure,and the other seven patients received CABG successfully and recovered well during a long-term follow up (18 to 108 months).Conclusions CAG is safe for children with Kawasaki disease with CAL,and the images of CAG are satisfied.Patients who were graded according to CAG and received the corresponding surgical treatment could get satisfied effect in the medium and long-term follow-up.
    • 王斐; 崔云; 王春霞; 肖婷婷; 陈容欣; 张育才
    • 摘要: 目的 探讨连续性静脉-静脉血液透析滤过(CVVHDF)在抢救儿童重症川崎病合并多器官功能障碍综合征(MODS)中的作用.方法 回顾性总结2015年11月至2017年10月上海交通大学附属儿童医院重症医学科(PICU)收治的川崎病合并MODS共5例患儿,采用CVVHDF辅助治疗,分析CVVHDF前后血液炎症细胞因子水平、器官功能变化与转归情况,组间比较采用Wilcoxon检验.结果 5例重症川崎病合并MODS患儿转入PICU时儿童危重评分(PCIS)74.0(70.0,81.0)分,第3代小儿死亡风险评分(PRISMⅢ)14.5(12.5,17.0)分.CVVHDF治疗时间46.0(24.5,48.0)h,均存活出院.CVVHDF治疗后白细胞介素6(IL-6) [0.4(0.1,28.8)比142.0(123.1,1 454.6) ng/L,Z=-2.023,P=0.043],肿瘤坏死因子α(TNF-α) [0.1 (0.1,9.3)比1.7(1.1,30.0) ng/L,Z=-2.023,P=0.0431,血乳酸[1.2(1.1,1.4)比2.5 (2.4,2.7) mmol/L,Z=-2.041,P=0.041],动脉氧分压(PaO2)/吸入氧浓度(FiO2)380.0(182.5,397.5)比160.0(52.5,185.0)mmHg(1 mmHg=0.133 kPa),Z=2.041,P=0.041]均明显改善;合并肝肾功能障碍的患儿总胆红素(TBIL)[(14.9±1.3)比(86.4±9.9) μmol/L],血肌酐(Cr)f2例,24.0比103.0 μmol/L,38.0比142.0 μmol/L]均恢复正常.结论 CVVHDF辅助抢救川崎病合并MODS能降低血液IL-6、TNF-α等炎症细胞因子水平,改善脏器功能,可能是重症川崎病合并MODS抢救有效辅助治疗手段.%Objective To explore the effects of continuous veno-venous hemodiafiltration (CVVHDF) as a rescue therapy in children with Kawasaki disease (KD) complicated with multiple organ dysfunction syndrome (MODS).Methods The medical records of 5 patients diagnosed as KD with MODS treated with CVVHDF,who were admitted to pediatric intensive care unit (PICU) of Shanghai Children's Hospital from November 2015 to October 2017 were retrospectively collected.The inflammatory factors and parameters of organ function before and after CVVHDF treatment were analyzed.Wilcoxon test was used to compare the changes of parameters before and after CVVHDF treatment.Results The pediatric critical illness score (PCIS) and the pediatric risk of score mortality score Ⅲ (PRISM Ⅲ) were 74.0 (70.0,81.0) and 14.5 (12.5,17.0),respectively.The duration of CVVHDF treatment was 46.0 (24.5,48.0) h.The levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-c),blood lactic acid were significantly decreased after the CVVHDF treatment (0.4 (0.1,28.8) vs.142.0 (123.1,1 454.6) ng/L,Z=-2.023,P=0.043;0.1 (0.1,9.3) vs.1.7(1.1,30.0) ng/L,Z=-2.023,P=0.043;1.2(1.1,1.4) vs.2.5(2.4,2.7) mmol/L,Z=-2.041,P=0.041 respectively).Moreover,the lung,liver and kidney function were significantly improved as indicated by the ratio of PaO2 to FiO2 (380.0 (182.5,397.5) vs.160.0 (52.5,185.0)mmHg (1 mmHg=0.133 kPa),Z=2.041,P=0.041),the level of total bilimbin ((14.9±1.3) vs.(86.4±9.9) μmol/L),and the levels of creatinine (2 cases:24.0 vs.103.0 μmol/L,38.0 vs.142.0 μmol/L).Conclusion CVVHDF as an adjuvant therapy can rapidly reduce the levels of IL-6 and TNF-α,and improve the organ functions in children with KD complicated with MODS.
    • 王在云
    • 摘要: 目的 探讨超声心动图对川崎病合并心力衰竭患儿心脏形态及功能评价价值.方法 选择2014年1月至2017年1月于忻州市人民医院超声科接受心脏检查的30例川崎病合并心力衰竭患儿为观察组,同时段健康儿童30例为对照组,均接受心脏超声检查.观察观察组与对照组心脏超声测量指标的差异,并比较观察组治疗前后心脏超声测量指标.结果 与对照组比较,观察组患儿左心房内径(LA)[(20.3±2.5)mm比(13.7 ±2.8)mm]、右心室内径(RV)[(13.8±2.3)mm比(10.5±1.9)mm]及左室舒张末期内径(LVDd)[(41.9 ±5.8)mm比(27.2±2.6) mm]指标显著升高,左室射血分数(LEVF)[(45.6±6.4)%比(70.3±8.4)%]、左心室短轴缩短率(LVFS)[(19.8±2.2)mL比(35.9±4.1)mL]及二尖瓣舒张早期峰值速度/舒张晚期峰值速度(E/A)(1.38±0.22比1.92±0.43)指标均显著降低,差异均有统计学意义(t=9.879、7.365、12.125、12.254、16.567、5.923,均P<0.05).治疗后,观察组超声测量指标均明显改善,其中结构参数LA[(20.3±2.5)mm比(16.5±2.2)]、RV[(13.8±2.3)mm比(11.4±1.3)]及LVDd[(41.9±5.8) mm比(33.7±3.3)]均明显降低,功能指标LVEF[(45.6±6.4)%比(59.9±7.1)%]、LVFS[(19.8±2.2)mL比(28.5±3.7) mL]及E/A[(1.38±0.22)比(1.73±0.31)]均明显升高,差异均有统计学意义(t=5.125、4.035、10.915、7.828、9.864、4.194,均P<0.05).结论 超声心动图能够客观地对川崎病合并心力衰竭患儿心脏形态学指标、功能指标以及治疗效果进行评价,临床应用价值高.%Objective To study value of the echocardiographic evaluation on Kawasaki disease of heart morphology and function.Methods From January 2014 to January 2017,30 cases of heart failure children with Kawasaki in the People's Hospital of Xinzhou were selected as observation group,at the same time 30 healthy volunteers were selected as control group,and they were all detected with echocardiography.The differences in cardiac ultrasound measurement were observed and compared between the observation group and normal control group,and before and after treatment,the heart ultrasonic measurement differences were compared between the two groups.Results Compared with those of the control group,the LA [(20.3 ± 2.5) mm vs.(13.7 ± 2.8) mm],RV [(13.8 ±2.3) mm vs.(10.5 ± 1.9) mm] and LVDd [(41.9 ± 5.8) mm vs.(27.2 ± 2.6) mm] index of the observation group were significantly increased,LVEF [(45.6 ± 6.4) % vs.(70.3 ± 8.4) %],LVFS [(19.8 ± 2.2) mL vs.(35.9 ±4.1) mL] and E/A [(1.38 ± 0.22) vs.(1.92 ± 0.43)] index of the observation group decreased significantly,the differences were statistically significant (t =9.879,7.365,12.125,12.254,16.567,5.923,all P < 0.05).Compared with those of the control group,the ultrasonic measurement indexes of the observation group were significantly improved,the structure parameters ofLA [(20.3±2.5)mm vs.(16.5±2.2)mm],RV[(13.8±2.3)mm vs.(11.4±1.3)mm] and LVDd[(41.9 ± 5.8)mm vs.(33.7 ± 3.3)mm] decreased obviously,function index of LVEF[(45.6 ± 6.4)% vs.(59.9 ±7.1)%],LVFS [(19.8±2.2)mL vs.(28.5±3.7)mL] andE/A[(1.38±0.22) vs.(1.73 ±0.31)]of the observation group were significantly increased after treatment,the differences were statistically significant (t =5.125,4.035,10.915,7.828,9.864,4.194,all P < 0.05).Conclusion Echocardiography can objectively evaluate the cardiac morphological indexes and functional indexes of children,which has high value in clinicalapplication.
    • 王婧; 张春霞; 雪梅; 张丹; 胡燕华; 张小杉
    • 摘要: 目的:分析超声心动图诊断川崎病(KD)冠状动脉损害(CAL)临床Ⅱ、Ⅲ、Ⅳ级损害的相关因素.方法:收集我院近5年的KD患儿416例为研究对象.经超声心动图检查发现,Ⅱ、Ⅲ、Ⅳ级损害179例,为病例组,未损害的237例为对照组.对两组的年龄、性别和血小板计数等44项可能为Ⅱ、Ⅲ、Ⅳ级损害的相关因素予以收集记录.资料在单因素分析的基础上又进行多因素Logistic回归分析.结果:热程每增加1d、血小板计数每增加1×109 L-1、血沉每增加1 mm/h、C反应蛋白每增加1μg/L和N末端脑钠肽前体每增加1 ng/L,促进Ⅱ、Ⅲ、Ⅳ级损害的危险分别是原来的1.254、2.813、1.073、3.845和1.083倍(均OR>1,其95%可信区间内均不包含1,均P<0.05),促进患病;男性Ⅱ、Ⅲ、Ⅳ级损害的危险是女性的12.276倍(OR>1,其95%可信区间内不包含1,P<0.05),亦促进患病;而应用丙种球蛋白(IVIG)及其应用初始时间为5~<10 d,促进Ⅱ、Ⅲ、Ⅳ级损害的危险分别是不应用IVIG和应用其初始时间为<5 d或≥10d的0.412及0.115倍(均OR<1,其95%可信区间内均不包含1,均P<0.05),阻止患病.结论:增加热程、血小板计数、血沉、C反应蛋白和N末端脑钠肽前体及男性为Ⅱ、Ⅲ、Ⅳ级损害的危险因素;而应用IVIG和应用初始时间5~9 d为其保护因素.
    • 宋瑞霞; 李晓惠; 张霆; 崔小岱; 伏瑾
    • 摘要: 目的 探讨血小板反应蛋白2(TSP-2)对川崎病患儿冠状动脉扩张的预测价值.方法 以回顾性病例对照研究的方法,分为川崎病组和对照组.收集2013年5月至2014年8月在首都儿科研究所附属儿童医院首次住院治疗的川崎病急性期患儿作为川崎病组,根据纳入标准共纳入64例,其中男39例、女25例,平均年龄2.3岁.根据超声心动图结果将川崎病组患儿分为冠状动脉扩张组(33例,其中男26例、女7例,平均年龄2.0岁)及冠状动脉非扩张组(31例,其中男13例、女18例,平均年龄2.6岁).对照组包括发热但除外血管炎性疾病的患儿及健康儿童,其中发热组32例,其中男19例、女13例,平均年龄4.5岁;健康组32名,其中男18名、女14名,平均年龄3.3岁.应用酶联免疫吸附试验(ELISA)法分别测定各组血浆中的TSP-2和TSP-1水平,并分析相关实验室指标及患儿基本信息.正态分布数据的多组比较使用方差分析,两组比较用两个独立样本t检验,用协方差分析去除年龄的影响.x2检验用于分析计数资料,受试者工作特征曲线(ROC曲线)用于评价TSP-2的预测价值.结果 川崎病组血浆TSP-2与TSP-1含量明显高于发热组及健康组[(33.6±12.5)比(21.4±8.8)及(16.4±2.9)μg/L,(10 949 ±7 241)比(7 174 ±4 807)及(3 661±2 672) μg/L,F=36.861、17.339,P均<0.01].TSP-2在冠状动脉扩张组中的表达明显高于非扩张组[(36.7±l3.1)比(30.4±11.1) μg/L,t=2.062,P=0.043].以ROC曲线分析TSP-2预测冠状动脉扩张时在截点为33.9μg/L时,敏感度为54.5%,特异度为80.6% (P <0.05).TSP-2联合血清白蛋白<35 g/L预测冠状动脉扩张时ROC曲线下面积为0.701,在截点为33.8 μg/L时,敏感度为60.0%,特异度为82.4%(P<0.05).结论 川崎病患儿急性期血浆TSP-2水平明显升高,血浆中升高的TSP-2水平可以预测川崎病患儿冠状动脉损伤的发生.TSP-2与血清白蛋白结合,其预测价值明显提高.%Objective To investigate the predictive value of thrombospondin-2 in children with coronary artery dilatation secondary to Kawasaki disease.Method This study was a retrospective controlled study,the patients were divided into Kawasaki disease group and control group.Patients first time hospitalized in Children's Hospital Affiliated to Capital Institute of Pediatrics during the acute phase of Kawasaki disease were enrolled in Kawasaki disease group from May 2013 to August 2014.Sixty-four Kawasaki disease patients were enrolled into the Kawasaki disease group based on inclusion and exclusion criteria,including 39 males and 25 females,with an average age of 2.3 years.According to the results of echocardiography of children with Kawasaki disease,patients were divided into coronary artery dilatation group and non-coronary artery dilatation group,there were 33 cases in the coronary dilatation (CAD) group,26 males and 7 females,the average age was 2.0 years,and 31 cases in the non-coronary dilatation (NCAD) group,13 males and 18 females,the average age was 2.6 years.The control group consisted of children with fever but excluding vascular inflammatory diseases and healthy children,32 cases in fever group,19 males and 13 females,mean age was 4.5 years;in which healthy group had 32 cases,18 males and 14 females and the average age was 3.3 years.Enzyme linked immunosorbent assay (ELISA) method was used to measure the levels of thrombospondin-1 (TSP-1) and TSP-2 in the plasma of each group,and the related laboratory parameters,and general information was analyzed.Multiple sets of normal distribution of data were compared by analysis of unifactorial analysis of variance and the two groups were compared by two independent samples t-test.Analysis of covariance was used to remove the effect of age.The x2 test was used to analyze categeorical data and receiver operating characteristic (ROC) curve for evaluating the predictive value of TSP-2.Result Compared with the febrile group and healthy group,plasma TSP-2 and TSP-1 of Kawasaki disease group was significantly elevated ((33.6 ± 12.5) vs.(21.4 ±8.8) and (16.4 ±2.9) μg/L,(10 949 ± 7 241) vs.(7 174 ± 4 807) and (3 661 ± 2 672) μg/L,F =36.861 and 17.339,P both < 0.01).The TSP-2 concentration in the group with coronary artery dilatation was significantly higher than the group without it ((36.7 ± 13.1) vs.(30.4 ± 1 1.1) μg/L,t =2.062,P =0.043).Regarding the predictive effect of TSP-2 for coronary artery dilatation,sensitivity was 54.5%,specificity was 80.6%,and the cut-off point was 33.9 μg/L.When TSP-2 was combined with albumin < 35 g/L to predict coronary artery dilatation,the area under the ROC curve was 0.701,sensitivity was 60.0%,specificity was 82.4%,and the cut-off point was 33.8 μg/L.Conclusion During the acute phase of Kawasaki disease,TSP-2 levels were significantly elevated.It could be used to predict the occurrence of coronary artery dilatation.The predictive value of TSP-2 was significantly improved when combined with albumin.
    • 赵晓英; 骆峰; 韦学
    • 摘要: 目的:探讨超声心动图检测川崎病冠状动脉病变的临床价值。方法:回顾性分析我院172例川崎病的超声心动图特点。结果:本组中,冠状动脉损害73例,阳性率42%,其中冠状动脉扩张60例,冠状动脉瘤13例;左冠状动脉受累38例(检出率52%);左右冠状动脉同时受累27例(检出率37%);右冠状动脉受累8例(检出率11%);双侧冠状动脉受损时左冠状动脉较右冠状动脉受损严重。结论:超声心动图可及时有效地评价川崎病患儿冠状动脉病变的发生率及动脉受损程度,给临床诊断及治疗提供依据。%Objective:To explore the value of ultrasonic cardiogram in assessing the coronary artery with Kawasaki disease. Methods:The ultrasonic cardiogram characteristics of 172 cases of children with Kawasaki disease were analyzed. Results:73 cases had coronary artery damage (42%),among them,51 cases with coronary artery expansion,6 cases with coronary aneurysm;38 cases with left coronary artery dilation (38/73,52%),27 cases with left and right coronary artery dilation (27/73,37%),8 cases with right coronary artery dilation (8/73,11%). When double coronary artery damaged,left coronary artery damaged more than right coronary artery. Conclusion:Ultrasonic cardiogram can evaluate the coronary artery damage for children with Kawasa-ki disease,and be helpful to make an early diagnosis and provide a basis treatment for clinic.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号